Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB1 | Q9H4B7 | 9/20 | 1.00 |
| ▸ | TUBB4A | P04350 | 8/20 | 1.00 |
| ▸ | TUBB | P07437 | 8/20 | 1.00 |
| ▸ | TUBA3C | P0DPH7 | 8/20 | 1.00 |
| ▸ | TUBA1B | P68363 | 8/20 | 1.00 |
| ▸ | TUBA4A | P68366 | 8/20 | 1.00 |
| ▸ | TUBB4B | P68371 | 8/20 | 1.00 |
| ▸ | TUBB3 | Q13509 | 8/20 | 1.00 |
| ▸ | TUBB2A | Q13885 | 8/20 | 1.00 |
| ▸ | TUBB8 | Q3ZCM7 | 8/20 | 1.00 |
| ▸ | TUBA3E | Q6PEY2 | 8/20 | 1.00 |
| ▸ | TUBA1A | Q71U36 | 8/20 | 1.00 |
| ▸ | TUBA1C | Q9BQE3 | 8/20 | 1.00 |
| ▸ | TUBB6 | Q9BUF5 | 8/20 | 1.00 |
| ▸ | TUBB2B | Q9BVA1 | 8/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 0.80 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.80 |
| ▸ | TSHR | P16473 | 2/20 | 0.80 |
| ▸ | MITF | O75030 | 1/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thiocolchicine SCHEMBL43161 | 1.00 | TUBB1 (1.00) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| Colchicine SCHEMBL2723855 | 0.97 | TUBB1 (0.95) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL12402699 | 0.94 | TUBB1 (0.88) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL13438483 | 0.93 | TUBB4A (0.88) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL2146845 | 0.93 | TUBB1 (1.00) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL12831823 | 0.93 | TUBB1 (1.00) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL23293732 | 0.92 | TUBB1 (0.85) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL12091271 | 0.92 | TUBB1 (0.85) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL13693049 | 0.92 | TUBB4A (0.84) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL13438474 | 0.91 | TUBB4A (0.83) | TUBB1TUBB4ATUBBTUBA3CTUBA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3638 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137636-A1 | TUMOR-TARGETING THIOCOLCHICINE NANOEMULSION | SMITH HENRY (US) | 2026-05-21 | — | — | US | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-12522572-B2 | Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-01-13 | — | — | US | claimed |
| US-20250325717-A1 | ANTI-NUCLEOPHOSMIN 1 ANTIBODY AND ANTIBODY CONJUGATE COMBINATION THERAPIES | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-10-23 | — | — | US | claimed |
| US-20250313647-A1 | MUTANT AND MISLOCALIZED CELL SURFACE NUCLEOPHOSMIN 1 AS A DIAGNOSTIC AND THERAPEUTIC TARGET OF HUMAN DISEASE | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-10-09 | — | — | US | claimed |
| US-20250288535-A1 | INSTANT NANOPARTICLE COMPOSITION AND PREPARATION METHOD THEREFOR | CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. (CN) | 2025-09-18 | — | — | US | claimed |
| EP-4590346-A1 | FIBROBLAST ACTIVATION PROTEIN (FAP) INHIBITORS, FAP CONJUGATES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF | Nuclidium AG (CH) | 2025-07-30 | — | — | EP | claimed |
| EP-4580677-A2 | SARS-COV2 ANTIBODIES AND USES THEREOF | Invivyd, Inc. (US) | 2025-07-09 | — | — | EP | claimed |
| CN-119677779-A | Combination therapy with anti-nucleolin 1 antibodies and antibody conjugates | 儿童医学中心公司 | 2025-03-21 | — | — | CN | claimed |
| EP-4514857-A2 | ANTI-NUCLEOPHOSMIN 1 ANTIBODY AND ANTIBODY CONJUGATE COMBINATION THERAPIES | The Children's Medical Center Corporation (US) | 2025-03-05 | — | — | EP | claimed |
| US-20030232837-A1 | 17-Beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | SCHERING CORPORATION | 2003-12-18 | — | — | US | claimed |
| CN-1122657-C | Colchicine-skeleton compounds, their use as medicaments and compounds containing them | INDENA SPA (IT) | 2003-10-01 | — | — | CN | claimed |
| EP-1313725-A1 | TRICYCLIC ANTITUMOR COMPOUNDS BEING FARNESYL PROTEIN TRANSFERASE INHIBITORS | SCHERING CORPORATION (US) | 2003-05-28 | — | — | EP | claimed |
| WO-2003033487-A1 | PIPERIDINE- AND PIPERAZINEACETAMINES AS 17BETA HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES | SCHERING CORPORATION (US) | 2003-04-24 | — | — | WO | claimed |
| WO-2003028527-A2 | DIAGNOSTIC OR THERAPEUTIC SOMATOSTATIN OR BOMBESIN ANALOG CONJUGATES AND USES THEREOF | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2003-04-10 | — | — | WO | claimed |
| WO-2003022835-A1 | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES | SCHERING CORPORATION (US) | 2003-03-20 | — | — | WO | claimed |
| US-20020198216-A1 | Novel farnesyl protein transferase inhibitors as antitumor agents | PHARMACOPEIA DRUG DISCOVERY | 2002-12-26 | — | — | US | claimed |
| WO-2002018368-A1 | TRICYCLIC ANTITUMOR COMPOUNDS BEING FARNESYL PROTEIN TRANSFERASE INHIBITORS | SCHERING CORPORATION (US) | 2002-03-07 | — | — | WO | claimed |
| CN-1219924-A | Colchicine-skeleton compounds, their use as medicaments and compounds containing them | INDENA SPA (IT) | 1999-06-16 | — | — | CN | claimed |
| US-4533675-A | ANTITUMOR, ANTICARCINOGENIC, ANTIARTHRITIC AGENTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1985-08-06 | — | — | US | claimed |